GlassScriptPhysician profile
Parvesh K Bansal
NPI 1548293442
$8,254.29
in general payments reported to CMS, 2019-2025
36 companies · $1,751 in 2025
The $1,751 reported for 2025 was more than what a typical Pulmonary Disease provider received nationally (typical 2025 total: $500).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $969 · 2020: $850 · 2021: $1,021 · 2022: $1,072 · 2023: $1,365 · 2024: $1,227 · 2025: $1,751.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,070 · Education: $273.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,069.98 |
| Education | $272.92 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $1,928.42 | 2019-2025 | Airsupra, Breztri, Tezspire |
| Glaxosmithkline, LLC. | $1,580.09 | 2019-2025 | Trelegy Ellipta, Arexvy, Nucala |
| Boehringer Ingelheim Pharmaceuticals, INC. | $980.83 | 2019-2025 | Ofev, Stiolto Respimat |
| Jazz Pharmaceuticals INC. | $775.49 | 2019-2025 | |
| Harmony Biosciences LLC | $641.46 | 2020-2025 | Wakix |
| Insmed, INC. | $208.66 | 2021-2025 | Arikayce |
| Takeda Pharmaceuticals U.S.A., INC. | $197.17 | 2020-2024 | Glassia, Cuvitru |
| Inspire Medical Systems, INC. | $188.68 | 2025 | Inspire |
| Philips North America LLC | $187.20 | 2019-2024 | (Ak6) Vest Therapy |
| Pulmonx Corporation | $160.52 | 2020-2025 | Chartis Catheter, Zephyr Delivery Catheter, Zephyr Endobronchial Valve |
| Grifols USA, LLC | $139.59 | 2021-2023 | Prolastin-C Liquid |
| United Therapeutics Corporation | $134.20 | 2022-2025 | Tyvaso |
| Boston Scientific Corporation | $125.00 | 2019 | |
| Shire North American Group INC | $124.06 | 2019 | |
| Axsome Therapeutics, INC. | $115.00 | 2022-2025 | Sunosi |
Show all 36 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Verona Pharma, INC. | $72.23 | 2025 | Ohtuvayre |
| Avadel Cns Pharmaceuticals, LLC | $68.94 | 2024-2025 | Lumryz |
| Electromed, INC. | $66.78 | 2022-2023 | Smartvest |
| Sunovion Pharmaceuticals INC. | $50.27 | 2019-2020 | |
| Mallinckrodt Hospital Products INC. | $47.50 | 2023-2025 | Acthar |
| Teva Pharmaceuticals USA, INC. | $45.66 | 2021-2022 | |
| Regeneron Healthcare Solutions, INC. | $45.56 | 2022 | |
| Mylan Specialty L.P. | $45.38 | 2019-2024 | Yupelri |
| Genzyme Corporation | $39.30 | 2021 | |
| Advanced Respiratory, INC | $35.86 | 2019-2020 | |
| Azurity Pharmaceuticals, INC. | $35.81 | 2025 | Alvesco |
| Fisher & Paykel Healthcare INC | $31.43 | 2019 | |
| Baxter Healthcare | $28.29 | 2025 | Hillrom - Vest System Model 105 Home Care |
| Pfizer INC. | $27.78 | 2019 | |
| Novo Nordisk INC | $22.21 | 2024 | Wegovy |
| Lilly USA, LLC | $21.63 | 2025 | Zepbound |
| Amgen INC. | $20.50 | 2023 | Tezspire |
| Circassia INC. | $18.31 | 2019 | |
| Inogen, INC. | $16.19 | 2023 | Inogen One G5 Oxygen Concentrator - Bluetooth |
| Idorsia Pharmaceuticals US INC | $15.99 | 2023 | Quviviq |
| Novartis Pharmaceuticals Corporation | $12.30 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Parvesh Bansal listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.